300497 富祥药业
已收盘 01-27 15:00:00
资讯
新帖
简况
富祥药业：预计2025年全年扣非后净利润亏损6900万元至8700万元
证券之星 · 01-26 20:03
富祥药业：预计2025年全年扣非后净利润亏损6900万元至8700万元
富祥药业（300497）披露副总经理辞职公告，1月23日股价上涨3.94%
证券之星 · 01-23
富祥药业（300497）披露副总经理辞职公告，1月23日股价上涨3.94%
富祥药业（300497）披露关于控股股东部分股份解除质押的公告，1月21日股价下跌0.59%
证券之星 · 01-21
富祥药业（300497）披露关于控股股东部分股份解除质押的公告，1月21日股价下跌0.59%
富祥药业：ODFB产品作为公司技术储备项目
证券之星 · 01-20
富祥药业：ODFB产品作为公司技术储备项目
富祥药业：锂电池添加剂生产依订单动态管理
证券之星 · 01-20
富祥药业：锂电池添加剂生产依订单动态管理
富祥药业（300497）披露公司股票期权激励计划调整及首次授予公告，1月16日股价上涨3.37%
证券之星 · 01-16
富祥药业（300497）披露公司股票期权激励计划调整及首次授予公告，1月16日股价上涨3.37%
富祥药业(300497.SZ)拟出让上海凌富39.2%股权 回笼资金
智通财经 · 01-09
富祥药业(300497.SZ)拟出让上海凌富39.2%股权 回笼资金
富祥药业：四季度亏损因计提资产减值
证券之星 · 01-08
富祥药业：四季度亏损因计提资产减值
富祥药业：公司生产和销售的VC产品的纯度一直是电子级99.999%
证券之星 · 01-08
富祥药业：公司生产和销售的VC产品的纯度一直是电子级99.999%
富祥药业（300497）披露控股股东部分股份解除质押，1月5日股价上涨4.3%
证券之星 · 01-05
富祥药业（300497）披露控股股东部分股份解除质押，1月5日股价上涨4.3%
每周股票复盘：富祥药业（300497）子公司获食品生产许可
证券之星 · 01-03
每周股票复盘：富祥药业（300497）子公司获食品生产许可
富祥药业（300497）披露为全资子公司提供担保进展，12月25日股价下跌0.79%
证券之星 · 2025-12-25
富祥药业（300497）披露为全资子公司提供担保进展，12月25日股价下跌0.79%
富祥药业涨6.09%，东吴证券一个月前给出“买入”评级
证券之星 · 2025-12-23
富祥药业涨6.09%，东吴证券一个月前给出“买入”评级
富祥药业（300497）披露第一期股票期权激励计划首次授予激励对象名单核查结果，12月9日股价下跌2.7%
证券之星 · 2025-12-09
富祥药业（300497）披露第一期股票期权激励计划首次授予激励对象名单核查结果，12月9日股价下跌2.7%
富祥药业：产品通过下游客户进入宁德时代供应链
证券之星 · 2025-12-04
富祥药业：产品通过下游客户进入宁德时代供应链
富祥药业：未冉蛋白获认证打开新成长空间
证券之星 · 2025-12-04
富祥药业：未冉蛋白获认证打开新成长空间
富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的
证券之星 · 2025-12-04
富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的
富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与
证券之星 · 2025-12-01
富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与
富祥药业(300497.SZ)拟授出不超620万份股票期权
智通财经 · 2025-11-27
富祥药业(300497.SZ)拟授出不超620万份股票期权
富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证
智通财经 · 2025-11-27
富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证
加载更多
公司概况
公司名称：
江西富祥药业股份有限公司
所属行业：
医药制造业
上市日期：
2015-12-22
主营业务：
江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售，在技术同源的基础上，拓展化学合成与生物合成的应用领域，大力发展锂电池电解液添加剂业务和拓展合成生物学微生物蛋白业务。公司的主要产品是医药制造业、锂离子电池产业链相关业务、微生物蛋白业务。
发行价格：
15.33
{"stockData":{"symbol":"300497","market":"SZ","secType":"STK","nameCN":"富祥药业","latestPrice":16.3,"timestamp":1769497401000,"preClose":16.45,"halted":0,"volume":40608031,"delay":0,"changeRate":-0.0091,"floatShares":441000000,"shares":539000000,"eps":-0.5065,"marketStatus":"已收盘","change":-0.15,"latestTime":"01-27 15:00:00","open":16.54,"high":16.76,"low":15.45,"amount":648000000,"amplitude":0.0796,"askPrice":16.31,"askSize":450,"bidPrice":16.3,"bidSize":830,"shortable":0,"etf":0,"ttmEps":-0.5065,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1769563800000},"marketStatusCode":5,"adr":0,"adjPreClose":16.45,"symbolType":"stock","openAndCloseTimeList":[[1769477400000,1769484600000],[1769490000000,1769497200000]],"highLimit":18.1,"lowLimit":14.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":538648934,"isCdr":false,"pbRate":4.12,"roa":"--","roe":"--","epsLYR":-0.51,"committee":-0.244885,"marketValue":8780000000,"turnoverRate":0.0921,"status":1,"floatMarketCap":7186000000},"requestUrl":"/m/hq/s/300497","defaultTab":"news","newsList":[{"id":"2606217913","title":"富祥药业：预计2025年全年扣非后净利润亏损6900万元至8700万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606217913","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606217913?lang=zh_cn&edition=full","pubTime":"2026-01-26 20:03","pubTimestamp":1769428981,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业发布业绩预告，预计2025年全年扣非后净利润亏损6900万元至8700万元。富祥药业2025年三季报显示，前三季度公司主营收入7.69亿元，同比下降21.24%；归母净利润-6275.15万元，同比下降1.09%；扣非净利润-8899.36万元，同比上升5.52%；其中2025年第三季度，公司单季度主营收入2.55亿元，同比下降13.51%；单季度归母净利润-5584.04万元，同比下降40.96%；单季度扣非净利润-5681.38万元，同比下降26.95%；负债率51.15%，投资收益-94.2万元，财务费用2690.9万元，毛利率12.05%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600031153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497"],"gpt_icon":0},{"id":"2605406732","title":"富祥药业（300497）披露副总经理辞职公告，1月23日股价上涨3.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605406732","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605406732?lang=zh_cn&edition=full","pubTime":"2026-01-23 22:52","pubTimestamp":1769179937,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，富祥药业报收于17.41元，较前一交易日上涨3.94%，最新总市值为93.78亿元。该股当日开盘16.92元，最高17.53元，最低16.63元，成交额达7.2亿元，换手率为9.47%。江西富祥药业股份有限公司董事会近日收到副总经理陈应惠先生提交的书面辞职报告，陈应惠先生因个人原因申请辞去公司副总经理职务，辞职后不再担任公司任何职务。其辞职自送达董事会之日起生效。陈应惠先生负责的工作已完成交接，离职不会对公司日常经营产生不利影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2605887354","title":"富祥药业（300497）披露关于控股股东部分股份解除质押的公告，1月21日股价下跌0.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605887354","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605887354?lang=zh_cn&edition=full","pubTime":"2026-01-21 22:17","pubTimestamp":1769005036,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，富祥药业报收于16.86元，较前一交易日下跌0.59%，最新总市值为90.82亿元。公司近日发布公告称，控股股东、实际控制人包建华先生于2026年1月20日将其持有的公司7,520,000股股份解除质押，占其所持股份比例6.94%，占公司总股本比例1.40%，质权人为景德镇农村商业银行股份有限公司昌江支行。本次解除质押后，包建华先生累计质押股份47,000,000股，占其所持股份比例43.36%。公司表示其质押股份不存在平仓风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012100040786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2604621641","title":"富祥药业：ODFB产品作为公司技术储备项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2604621641","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604621641?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:04","pubTimestamp":1768892654,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问：根据公司半年报介绍：兼具新型锂盐和成膜添加剂的功能的ODFB（二氟草酸硼酸锂）已经开始商业化生产，请介绍一下新一代锂电添加剂ODFB业务（产能，下游合作客户）富祥药业回复：尊敬的投资者您好，ODFB产品作为公司技术储备项目，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000017960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300497","BK0201"],"gpt_icon":0},{"id":"2604162968","title":"富祥药业：锂电池添加剂生产依订单动态管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2604162968","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604162968?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:04","pubTimestamp":1768892654,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问：介绍一下公司2026年一季度锂电池添加剂碳酸亚乙烯酯排产以及春节期间是否满产？富祥药业回复：尊敬的投资者您好，公司锂电池电解液添加剂产品的生产计划依据市场订单需求、库存情况以及年度生产规划进行动态制定与管理。春节期间，公司将统筹安排，确保订单交付与生产系统的稳定运行。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012000017967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2603991195","title":"富祥药业（300497）披露公司股票期权激励计划调整及首次授予公告，1月16日股价上涨3.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991195","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603991195?lang=zh_cn&edition=full","pubTime":"2026-01-16 22:13","pubTimestamp":1768572794,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，富祥药业报收于16.56元，较前一交易日上涨3.37%，最新总市值为89.2亿元。根据近日发布的第五届董事会第六次会议决议公告，江西富祥药业股份有限公司于2026年1月16日召开第五届董事会第六次会议，审议通过多项议案。因1名激励对象放弃获授，公司第一期股票期权激励计划激励对象由50人调整为49人，股票期权总数由620万份调整为605万份，首次授予数量由505万份调整为490万份，预留数量115万份不变。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011600040912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2602324718","title":"富祥药业(300497.SZ)拟出让上海凌富39.2%股权 回笼资金","url":"https://stock-news.laohu8.com/highlight/detail?id=2602324718","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602324718?lang=zh_cn&edition=full","pubTime":"2026-01-09 18:26","pubTimestamp":1767954378,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)公告，公司拟与上海凌凯科技股份有限公司(“上海凌凯”)签署《股权转让协议》，将持有的上海凌富药物研究有限公司(“上海凌富”)39.20%股权以4277万元的价格转让给上海凌凯，本次交易完成后，公司将不再持有上海凌富股权。此举旨在通过股权转让实现资金回笼、降低投资风险，集中资源巩固与提升主业核心竞争力。同时，公司期望通过优化投资结构，进一步增强资产流动性和整体抗风险能力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391040.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2601835113","title":"富祥药业：四季度亏损因计提资产减值","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601835113?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:30","pubTimestamp":1767861036,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，2021四季度亏1.122亿元，2022四季度亏损1.874亿元，2023四季度亏损1.192亿元，2024四季度亏损2.1亿元，2025四季度？。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800024347.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300497","BK0201"],"gpt_icon":0},{"id":"2601351629","title":"富祥药业：公司生产和销售的VC产品的纯度一直是电子级99.999%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601351629","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601351629?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:27","pubTimestamp":1767860835,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)01月08日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好！我们知道公司的VC生产成本是行业内最低的，VC纯度99.995%，通过了三星SDI、LG化学及国内主流电解液厂认证，请问何时才能将VC纯度提高到电子级99.999%呢？谢谢！富祥药业回复：尊敬的投资者您好，公司生产和销售的VC产品的纯度一直是电子级99.999%。感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800023921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300497","BK0239"],"gpt_icon":0},{"id":"2601800784","title":"富祥药业（300497）披露控股股东部分股份解除质押，1月5日股价上涨4.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601800784","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601800784?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:48","pubTimestamp":1767606503,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，富祥药业报收于15.76元，较前一交易日上涨4.3%，最新总市值为84.89亿元。公司近日发布公告称，控股股东、实际控制人包建华先生于2025年12月30日解除质押其持有的公司股份11,000,000股，占其所持股份比例10.15%，占公司总股本比例2.04%，质权人为九江银行股份有限公司景德镇分行。本次解除质押后，包建华先生累计质押股份54,520,000股，占其所持股份比例50.30%。公告显示，其质押股份不存在平仓风险，具备资金偿还能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500026317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","300497","BK0239"],"gpt_icon":0},{"id":"2600706239","title":"每周股票复盘：富祥药业（300497）子公司获食品生产许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2600706239","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600706239?lang=zh_cn&edition=full","pubTime":"2026-01-03 01:45","pubTimestamp":1767375912,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，富祥药业报收于15.11元，较上周的16.08元下跌6.03%。本周关注点公司公告汇总：子公司取得食品生产许可证，具备年产1200吨未冉蛋白产能。本次质押后，包建华累计质押股份65,520,000股，占其所持股份比例60.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2594233237","title":"富祥药业（300497）披露为全资子公司提供担保进展，12月25日股价下跌0.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594233237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594233237?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:35","pubTimestamp":1766673322,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，富祥药业报收于15.07元，较前一交易日下跌0.79%，最新总市值为81.17亿元。公司近日发布公告称，江西富祥药业股份有限公司为全资子公司景德镇市富祥生命科技有限公司向招商银行景德镇分行申请的最高不超过人民币3000万元授信额度提供连带责任保证担保，担保期限自2025年12月16日起至2028年12月15日止。截至公告日，公司累计对外担保总额度12.29亿元，实际担保余额7.515亿元，占最近一期经审计净资产的34.47%，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2593676194","title":"富祥药业涨6.09%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2593676194","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593676194?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:36","pubTimestamp":1766475417,"startTime":"0","endTime":"0","summary":"今日富祥药业（300497）涨6.09%，收盘报14.81元。2025年11月12日，东吴证券研究员朱国广发布了对富祥药业的研报《电解液添加剂涨价点评：VC价格快速上涨贡献利润弹性》，该研报对富祥药业给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为6.47%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为天风证券的潘海洋。富祥药业（300497）个股概况：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300019480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","601555"],"gpt_icon":0},{"id":"2590935314","title":"富祥药业（300497）披露第一期股票期权激励计划首次授予激励对象名单核查结果，12月9日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590935314","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590935314?lang=zh_cn&edition=full","pubTime":"2025-12-09 17:43","pubTimestamp":1765273410,"startTime":"0","endTime":"0","summary":"截至2025年12月9日收盘，富祥药业报收于14.43元，较前一交易日下跌2.7%，最新总市值为77.73亿元。公司近日发布公告称，江西富祥药业股份有限公司于2025年11月27日召开第五届董事会第四次会议，审议通过公司第一期股票期权激励计划（草案）及其摘要。根据相关规定，公司对首次授予激励对象的姓名和职务进行了内部公示，公示时间为2025年11月28日至12月7日，通过张贴方式公示，未收到任何异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900027439.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","300497"],"gpt_icon":0},{"id":"2588884862","title":"富祥药业：产品通过下游客户进入宁德时代供应链","url":"https://stock-news.laohu8.com/highlight/detail?id=2588884862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588884862?lang=zh_cn&edition=full","pubTime":"2025-12-04 20:48","pubTimestamp":1764852514,"startTime":"0","endTime":"0","summary":"公司产品通过下游客户进入锂电池产业链，最终应用于包括宁德时代在内的锂电池生产商。关于具体的客户认证及供应关系，涉及公司与合作方的商业约定，公司依据信息披露相关规定履行披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400036788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1152091754.HKD","LU2152927971.USD","BK0239","LU2097828631.EUR","LU1251922891.USD","LU0051755006.USD","LU0228659784.USD","300497","LU0143863198.USD","LU0327786744.USD","LU1048596156.SGD","03750","SG9999001846.SGD","LU0828237510.HKD","LU0348805143.USD","LU0516423091.SGD","IE00B543WZ88.USD","EVS.SI","LU1146622755.USD","IE0032431581.USD","LU1769817096.USD","300750","LU0244354667.USD","LU2348774022.SGD","LU0543330483.HKD","LU0106259558.USD","LU0124384867.USD","LU2506952253.HKD","LU1997245177.USD","LU1008478684.HKD","SG9999001689.USD","LU0828237940.HKD","LU0572944931.SGD","SG9999001903.USD","LU0049853897.USD","LU1721428347.USD","LU2476274720.SGD","LU0359201885.HKD","LU2039709279.SGD","LU2097828557.USD","LU0054450605.USD","LU0531971595.HKD","LU0607220059.USD","LU1303224171.USD","LU1769817179.HKD","LU1979443071.USD","LU2153591404.USD","LU1813983027.USD","LU3063872942.SGD","LU0132412106.USD"],"gpt_icon":0},{"id":"2588072150","title":"富祥药业：未冉蛋白获认证打开新成长空间","url":"https://stock-news.laohu8.com/highlight/detail?id=2588072150","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588072150?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:33","pubTimestamp":1764819206,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业12月03日在投资者关系平台上答复投资者关心的问题。富祥药业回复：尊敬的投资者您好，截至目前公司已具备年产1200吨未冉蛋白的生产能力，并正在加速推进年产2万吨未冉蛋白项目建设。公司未冉蛋白已于近期正式通过国家卫健委新食品原料认证，标志着该产品获得了在国内市场生产销售的资格，其成功获批为公司打开了全新的成长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400013193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300497","BK0201","BK0239"],"gpt_icon":0},{"id":"2588507212","title":"富祥药业：公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的","url":"https://stock-news.laohu8.com/highlight/detail?id=2588507212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588507212?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:33","pubTimestamp":1764819201,"startTime":"0","endTime":"0","summary":"证券之星消息，富祥药业(300497)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：据称公司外购亚硫酸乙烯酯es原料已经高达15万每吨，请问公司为什么不自己生产该原料富祥药业回复：尊敬的投资者您好，公司原材料采购与生产策略是基于市场需求、成本效益、技术积累及供应链安全等多方面因素综合制定的，公司将持续评估产业链布局，以提升整体竞争力，感谢您的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400013190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2588711292","title":"富祥药业：11月28日接受机构调研，山西证券、国元证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2588711292","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588711292?lang=zh_cn&edition=full","pubTime":"2025-12-01 09:08","pubTimestamp":1764551320,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月30日富祥药业发布公告称公司于2025年11月28日接受机构调研，山西证券、国元证券、九方智投、瑞奇期货、承风金萍基金、信迹投资、李蓬勃,胡晓俊参与。另外，富祥未冉蛋白已取得中国、美国、新加坡、欧洲等国家有关部门准入许可，为其全球化商业运用奠定了坚实基础。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100000662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0276","BK0012","BK0028","BK0201","BK0183","002500","300497","000728","BK0239","BK0188"],"gpt_icon":0},{"id":"2586242722","title":"富祥药业(300497.SZ)拟授出不超620万份股票期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2586242722","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586242722?lang=zh_cn&edition=full","pubTime":"2025-11-27 19:49","pubTimestamp":1764244195,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)披露第一期股票期权激励计划(草案)，公司拟向激励对象授予不超过620万份的股票期权(首次授予不超过505万份)，行权价格为16.15元/股。首次授予的激励对象不超过50人。本激励计划的有效期自股票期权首次授予之日起至激励对象获授的股票期权全部行权或注销之日止，最长不超过60个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0201","300497"],"gpt_icon":0},{"id":"2586458472","title":"富祥药业(300497.SZ)：威尼斯镰刀菌蛋白通过新食品原料认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2586458472","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586458472?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:13","pubTimestamp":1764234799,"startTime":"0","endTime":"0","summary":"智通财经APP讯，富祥药业(300497.SZ)公告，国家卫生健康委员会(简称“国家卫健委”)近日发布了《关于威尼斯镰刀菌蛋白等14种“三新食品”的公告》，根据《食品安全法》规定，国家卫健委审评机构组织专家对威尼斯镰刀菌蛋白物质申请新食品原料的安全性评估材料进行审查并通过。该项公告的发布，标志着由公司子公司江西富祥生物科技有限公司(简称“富祥生物”)向国家卫健委提出的关于威尼斯镰刀菌蛋白新食品原料行政许可审批获得通过，富祥未冉蛋白将可作为新食品原料在国内进行生产、销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1374498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300497","BK0201"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1769504926803,"stockEarnings":[{"period":"1week","weight":-0.053},{"period":"1month","weight":0.023},{"period":"3month","weight":0.6127},{"period":"6month","weight":0.6255},{"period":"1year","weight":1.0929},{"period":"ytd","weight":0.0887}],"compareEarnings":[{"period":"1week","weight":0.0045},{"period":"1month","weight":0.0426},{"period":"3month","weight":0.0362},{"period":"6month","weight":0.143},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.0413}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西富祥药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20651人(较上一季度减少7.87%)","perCapita":"21347股","listingDate":"2015-12-22","address":"江西省景德镇市昌江区鱼丽工业区2号(鱼山与丽阳交界处)","registeredCapital":"53864万元","survey":" 江西富祥药业股份有限公司的主营业务是抗感染药物原料药、中间体的研发、生产和销售，在技术同源的基础上，拓展化学合成与生物合成的应用领域，大力发展锂电池电解液添加剂业务和拓展合成生物学微生物蛋白业务。公司的主要产品是医药制造业、锂离子电池产业链相关业务、微生物蛋白业务。","listedPrice":15.33},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"富祥药业(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供富祥药业(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"富祥药业,300497,富祥药业股票,富祥药业股票老虎,富祥药业股票老虎国际,富祥药业行情,富祥药业股票行情,富祥药业股价,富祥药业股市,富祥药业股票价格,富祥药业股票交易,富祥药业股票购买,富祥药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"富祥药业(300497)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供富祥药业(300497)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}